Amy M. Kempf
Goettingen, NI 37077, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Searching for Novel Antiviral Agents as COVID19 Treatments: Guanidino Diaryl Thioureas.
Journal: ChemMedChem
Published: November 07, 2025
Humoral Immune Responses in Dialysis Patients After mRNA Omicron JN.1 Vaccination.
Journal: Kidney medicine
Published: September 08, 2025
Neutralizing activity against bovine H5N1 HPAIV (clade 2.3.4.4b) in human plasma after seasonal influenza vaccination.
Journal: Emerging microbes & infections
Published: July 01, 2025
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
Journal: Virology
Published: June 20, 2025
Polyvalent Mannuronic Acid-Coated Gold Nanoparticles for Probing Multivalent Lectin-Glycan Interaction and Blocking Virus Infection.
Journal: Viruses
Published: May 31, 2025
Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2.
Journal: The Lancet. Microbe
Published: May 09, 2025
Host cell entry and neutralisation sensitivity of the emerging SARS-CoV-2 variant LP.8.1.
Journal: The Lancet. Infectious diseases
Published: January 28, 2025
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
Journal: Journal of virology
Published: January 10, 2025
Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells.
Journal: Journal of virology
Published: October 29, 2024
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC.
Journal: The Lancet. Infectious diseases
Published: October 03, 2024
Last Updated: 09/26/2026